Get the Stockscreener App
1.32
1.54%
0.02
Bioaffinity Technologies Inc stock is traded at $1.32, with a volume of 28,213.
It is up +1.54% in the last 24 hours and up +12.82% over the past month.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
See More
Previous Close:
$1.30
Open:
$1.29
24h Volume:
28,213
Relative Volume:
0.28
Market Cap:
$5.80M
Revenue:
$9.37M
Net Income/Loss:
$-8.45M
P/E Ratio:
-1.6296
EPS:
-0.81
Net Cash Flow:
$-7.27M
1W Performance:
+0.76%
1M Performance:
+12.82%
6M Performance:
-86.83%
1Y Performance:
-93.84%
1-Day Range:
$1.25
$1.33
1-Week Range:
$1.25
$1.4399
52-Week Range:
$1.1101
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.29 | 5.85M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
624.11 | 235.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.35 | 167.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
697.90 | 55.72B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
242.05 | 40.77B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.71 | 38.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
Aug Analyst Calls: What is bioAffinity Technologies Inc Equity Warrants valuation compared to sectorEarnings Miss & AI Optimized Trade Strategies - baoquankhu1.vn
Stock Recap: What are the future prospects of bioAffinity Technologies Inc Equity WarrantJuly 2025 Sentiment & Consistent Income Trade Ideas - baoquankhu1.vn
Bank Watch: Will bioAffinity Technologies Inc benefit from sector rotationJuly 2025 Recap & Daily Profit Focused Screening - baoquankhu1.vn
Earnings Recap: What are the future prospects of bioAffinity Technologies Inc Equity WarrantEarnings Overview Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Market Trends: Is bioAffinity Technologies Incs growth already priced inShare Buyback & Weekly Top Gainers Alerts - baoquankhu1.vn
bioAffinity Adjourns Special Stockholder Meeting for Lack Quorum - MSN
Why bioAffinity Technologies Inc. Equity Warrant stock appeals to dividend seekersPortfolio Value Report & Fast Entry Momentum Alerts - Улправда
Will bioAffinity Technologies Inc. stock pay special dividendsJuly 2025 Sector Moves & Low Risk High Win Rate Picks - Улправда
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - FinancialContent
Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growth2025 Key Lessons & Weekly Momentum Picks - Улправда
Is bioAffinity Technologies Inc. stock trading at a premium valuation2025 Dividend Review & Advanced Technical Analysis Signals - ulpravda.ru
Will bioAffinity Technologies Inc. stock outperform tech sector in 2025Quarterly Growth Report & Free Fast Entry Momentum Trade Alerts - Улправда
Is bioAffinity Technologies Inc. Equity Warrant stock cheap compared to fundamentalsJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - Улправда
Is bioAffinity Technologies Inc. stock ready for breakoutJuly 2025 Weekly Recap & AI Driven Price Predictions - ulpravda.ru
Can bioAffinity Technologies Inc. stock maintain growth trajectoryWeekly Market Summary & Detailed Earnings Play Strategies - Улправда
Is bioAffinity Technologies Inc. Equity Warrant stock a buy for dividend growthMarket Volume Summary & AI Powered Market Trend Analysis - ulpravda.ru
Will bioAffinity Technologies Inc. stock attract ESG investorsWeekly Trade Summary & Stock Timing and Entry Methods - Улправда
Will bioAffinity Technologies Inc. Equity Warrant stock attract ESG investors2025 Fundamental Recap & Daily Chart Pattern Signals - Улправда
How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peersFundamental Stock Analysis & Small Entry Cost Stocks - Улправда
bioAffinity Labs Maintain CAP Accreditation, Supporting CyPath Lung - TipRanks
bioAffinity Technologies Maintains CAP Accreditation - TradingView — Track All Markets
bioAffinity Technologies (BIAF) lab unit keeps College of American Pathologists accreditation - Stock Titan
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation - Business Wire
2026 world cup star players explained: How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers2026 world cup usa national team round of 32 playmakers low block defense odds analysis preview - ulpravda.ru
bioAffinity Technologies Inc. (BIAF) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 10.8% – Here’s What Happened - Defense World
bioAffinity Technologies (NASDAQ:BIAF) Stock Price Down 4.9% – Here’s What Happened - Defense World
What drives bioAffinity Technologies Inc Equity Warrant stock priceMarket Liquidity Analysis & High Yield Market Growth - earlytimes.in
Bearish Setup: Will bioAffinity Technologies Inc stock pay special dividendsCPI Data & Weekly Momentum Stock Picks - moha.gov.vn
bioAffinity Technologies reports transfer of Village Oaks Pathology ownership By Investing.com - Investing.com Nigeria
bioAffinity Technologies reports transfer of Village Oaks Pathology ownership - Investing.com
bioAffinity Updates Village Oaks Physician Succession Agreement - TipRanks
bioAffinity Technologies Announces Succession Agreement - TradingView — Track All Markets
Is bioAffinity Technologies Inc. stock a defensive play in 2025Trade Volume Summary & Community Trade Idea Sharing Platform - Улправда
Energy Moves: How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Will bioAffinity Technologies Inc. stock return to pre crisis levelsJuly 2025 Setups & Free Long-Term Investment Growth Plans - Улправда
Nasdaq Moves: Why bioAffinity Technologies Inc. stock could be next big winnerQuarterly Trade Report & Community Verified Watchlist Alerts - moha.gov.vn
How bioAffinity Technologies Inc. Equity Warrant stock trades during market volatilityJuly 2025 Chart Watch & Free Verified High Yield Trade Plans - Улправда
bioAffinity Technologies Earnings Notes - Trefis
Will bioAffinity Technologies Inc. Equity Warrant stock deliver strong dividend growthWeekly Stock Summary & Real-Time Market Sentiment Reports - Улправда
Market Catalysts: Is bioAffinity Technologies Inc. stock a defensive play in 2025Weekly Investment Recap & Safe Investment Capital Preservation Plans - Улправда
bioAffinity Technologies adjourns special shareholder meeting due to lack of quorum - Investing.com Nigeria
bioAffinity Technologies adjourns special shareholder meeting due to lack of quorum By Investing.com - Investing.com South Africa
bioAffinity Technologies Adjourns Special Meeting - TradingView — Track All Markets
New Highs: Why bioAffinity Technologies Inc. stock could be next big winner - Улправда
Rate Hike: Can bioAffinity Technologies Inc. stock maintain growth trajectoryQuarterly Risk Review & Free High Accuracy Swing Entry Alerts - DonanımHaber
Is bioAffinity Technologies Inc. Equity Warrant stock dividend yield sustainablePortfolio Return Summary & Advanced Technical Analysis Signals - DonanımHaber
Trading Recap: Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growthInsider Buying & AI Forecasted Stock Moves - DonanımHaber
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):